FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

18177111000001105: Zoton FasTab 30mg (Mawdsley-Brooks & Company Ltd) 28 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Dec 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
62410601000001112 Zoton FasTab 30mg (Mawdsley-Brooks & Company Ltd) 28 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
62410701000001119 Zoton FasTab 30mg (Mawdsley-Brooks & Company Ltd) 28 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zoton FasTab 30mg (Mawdsley-Brooks & Company Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zoton FasTab 30mg (Mawdsley-Brooks & Company Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Zoton FasTab 30mg (Mawdsley-Brooks & Company Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Zoton FasTab 30mg (Mawdsley-Brooks & Company Ltd) 28 tablet Is a Lansoprazole 30mg orodispersible gastro-resistant tablets 28 tablet true Inferred relationship Existential restriction modifier
Zoton FasTab 30mg (Mawdsley-Brooks & Company Ltd) 28 tablet Has AMP Zoton FasTab 30mg (Mawdsley-Brooks & Company Ltd) true Inferred relationship Existential restriction modifier
Zoton FasTab 30mg (Mawdsley-Brooks & Company Ltd) 28 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zoton FasTab 30mg (Mawdsley-Brooks & Company Ltd) 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zoton FasTab 30mg (Mawdsley-Brooks & Company Ltd) 28 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zoton FasTab 30mg (Mawdsley-Brooks & Company Ltd) 28 tablet Has specific active ingredient Lansoprazole true Inferred relationship Existential restriction modifier
Zoton FasTab 30mg (Mawdsley-Brooks & Company Ltd) 28 tablet Has dispensed dose form Orodispersible tablet false Inferred relationship Existential restriction modifier
Zoton FasTab 30mg (Mawdsley-Brooks & Company Ltd) 28 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Zoton FasTab 30mg (Mawdsley-Brooks & Company Ltd) 28 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Zoton FasTab 30mg (Mawdsley-Brooks & Company Ltd) 28 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Zoton FasTab 30mg (Mawdsley-Brooks & Company Ltd) 28 tablet Has dispensed dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Zoton FasTab 30mg (Mawdsley-Brooks & Company Ltd) 28 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start